<DOC>
	<DOCNO>NCT00000442</DOCNO>
	<brief_summary>This study evaluate safety effectiveness injectable slow release preparation naltrexone reduce alcohol consumption risk relapse alcohol-dependent subject . Individuals receive either naltrexone placebo injection total three month , two subsequent followup visit span 6- month period .</brief_summary>
	<brief_title>Naltrexone Relapse Prevention</brief_title>
	<detailed_description />
	<mesh_term>Alcoholism</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>Meets criteria alcohol dependence . Abstinent alcohol period least 3 day prior begin study . Able read English complete study evaluation . Females postmenopausal , surgical sterilization , use reliable mean birth control . Meets criteria dependence psychoactive substance alcohol nicotine and/or cannabis . Prior history opioid dependence . Regular use psychoactive drug include anxiolytic antidepressant . Prior treatment naltrexone . Current use disulfiram . Psychotic otherwise severely psychiatrically disabled ( e.g. , suicidal , current mania ) . Significant underlying medical condition hepatic , cerebral , renal , thyroid , cardiac disease . Abstinent longer 28 day prior randomization .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2011</verification_date>
</DOC>